Stocks making the biggest moves premarket: Starbucks, AMD, Pearson, PacWest & more

Market Insider

In this article

general view of a Starbucks store on September 15, 2022 in Plainview, New York
Bruce Bennett | Getty Images News | Getty Images

Check out the companies making headlines in premarket trading.

Eli Lilly — The pharmaceutical stock rose more than 5% on clinical trial data showing that the company’s donanemab drug slowed the progression of Alzheimer’s disease.

Starbucks — Shared of the popular coffee chain fell 5% before the bell even after beating analyst estimates and posting stronger-than-expected same-store sales growth. Starbucks reaffirmed its outlook.

AMD — The semiconductor stock fell more than 7% in premarket trading after quarterly results a day earlier. The company reported an adjusted 60 cents per share on $5.35 billion in revenue, which were both ahead of analyst expectations of 56 cents and $5.3 billion, according to Refinitiv. Guidance for sales for the current quarter was lower from the company, however, and analysts are now split on how to view the stock.

Chegg — Shares of the online book renter regained 6.2% on Wednesday after falling as much as 48% a day earlier. The company noted concern of the rise of artificial intelligence as a threat to the core business on its earnings call. CEO Dan Rosensweig also said that the panic that sent the stock plunging was ”extraordinarily overblown.”

PacWest, Western Alliance — Regional bank stocks were poised to extend their losses for the week on Wednesday morning. PacWest’s shares fell 4.6% in premarket trading after sliding nearly 28% on Tuesday. Western Alliance was down more than 3% after shedding 15% on Tuesday. Shares have been under pressure amid renewed concern over the health of the sector.

Biogen — The biotech company declined about 4% on Wednesday, after Eli Lilly reported its Alzheimer’s drug trial data. Biogen reported earnings last week, notching an adjusted $3.40 per share while analysts polled by StreetAccount forecasted $3.28. The company recently received authorization from the Food and Drug Administration for an ALS treatment drug.

Cogent — Shares of the communications and internet company gained 2.8% after a Bank of America upgrade. Cogent said Tuesday it had closed on a plan acquisition of Sprint’s wireless network from T-Mobile.

Match Group — Shares rose 2.7% in light volume during premarket trading. The online dating company reported first-quarter earnings that topped analysts estimates from Refinitiv after the bell Tuesday. However, Match’s revenue missed expectations.

Generac — The energy technology company gained 6.5% after quarterly earnings beat analyst expectations. Generac reported an adjusted 63 cents per share against an expected 48 cents, according to StreetAccount.

Pearson — Pearson shares popped more than 8%. The stock was double upgraded to buy from underperform by Bank of America, which said Tuesday’s sell-off in the stock, which followed a sharp decline in Chegg amid AI worries, was “overly harsh.”

— CNBC’s Samantha Subin, Jesse Pound and Michelle Fox Theobald contributed reporting

Articles You May Like

An options strategy to generate income on this ‘Dog of the S&P 500’ – and perhaps buy it cheap
Nvidia sees ‘remarkable’ influx of retail investor dollars as traders flock to AI darling
Top Wall Street analysts recommend these dividend stocks for higher returns
Quantum Computing Revolution: The Gargantuan Opportunity Investors Shouldn’t Ignore
My Top 10 Stock Market Predictions for 2025